2025. Integrated Safety Analysis of Ruxolitinib Cream: Data From 20 Clinical Studies in Inflammatory Dermatologic Conditions. SKIN The Journal of Cutaneous Medicine. 9, 6 (Nov. 2025), s711. DOI:https://doi.org/10.25251/36mxmk39.